Back to Report Store Home

Nutraceuticals: New Applications for Probiotics, Genetic Modification and Diet as Products Make Gains in Rx Territory

  • Published: Dec-2017
  • Report Code: GBI085CBR
  • Report Format: pdf

Description

Table of Contents

1 Table of Contents 3

1.1 List of Tables 4

1.2 List of Figures 4

2 Nutraceuticals Overview 5

2.1 An Unclear Definition of Nutraceuticals 5

2.2 Divide between Consumer-Oriented Products and Medical Foods 6

3 Key Nutraceutical Products - Case Studies 11

3.1 Souvenaid – Nutricia 11

3.2 Impact products – Nestlé Health Sciences 12

3.3 Deplin – Alfasigma 13

3.4 Vascepa – Amarin 14

3.5 Epanova – AstraZeneca 14

3.6 Meritene products – Nestlé Health Sciences 15

3.7 Pedialyte – Abbott 15

3.8 Tolerase L – DSM Nutritional Products 16

3.9 Armolipid Plus – Meda 17

4 Key Companies Involved in the Nutraceutical Market 18

4.1 Nestlé Health Sciences 18

4.2 Abbott Nutrition 20

4.3 Alfasigma USA 21

4.4 GlaxoSmithKline 21

4.5 Takeda 22

4.6 Danone 23

5 Regulatory Landscape and Promising Markets 25

5.1 The US: FDA (Food and Drug Administration) 25

5.1.1 Nutraceuticals as Drugs 25

5.1.2 Medical Foods 25

5.1.3 Foods for Special Dietary Use 26

5.1.4 Dietary Supplements 27

5.2 Europe 28

5.2.1 Supplements 28

5.2.2 Particular Nutritional Requirements of Specific Groups of the Populations (PARNUTS) Foods 29

5.2.3 Nutraceuticals Classified as General Foods 29

5.3 Japan 29

5.3.1 Food with Functional Nutrient Claims 30

5.3.2 Food for Special Dietary Uses 30

5.3.3 Foods for Specified Health Uses 30

5.4 Promising markets 31

6 Outlook for Nutraceuticals and Key Future Trends 32

6.1 Industry Sentiment and Growth Areas 32

6.2 Upcoming Companies- Case Studies 35

6.2.1 Biomeb: A company providing genetic and metabolic counseling and novel nutraceutical ingredients 35

6.3 Lycored: Successful despite failure to achieve regulatory clearance to list health benefits for key products 36

6.3.1 Cambridge Nutraceuticals: Experience of both sides of nutraceutical marketing regulations 36

6.4 The Microbiome and New Avenues for Nutraceuticals 37

6.5 Genetically Modified Organisms as Nutraceuticals 38

6.6 Barriers to Growth in the Nutraceutical Industry 39

6.7 Unclear Public Understanding of What Nutraceuticals Are 42

6.8 Reaching the Right Consumer Groups 42

6.9 Price 42

6.10 Perception of Nutraceuticals 42

6.11 Difficulty Proving Efficacy 43

6.12 Conclusion 43

7 Appendix 45

7.1 References 45

7.2 Abbreviations 47

7.3 Contact Us 48

7.4 Disclaimer 49

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$2995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$5990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$8985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards